Edition:
India

People: Cintas Corp (CTAS.OQ)

CTAS.OQ on NASDAQ Stock Exchange Global Select Market

338.50USD
22 Oct 2020
Change (% chg)

$0.00 (+0.00%)
Prev Close
$338.50
Open
$340.29
Day's High
$341.09
Day's Low
$334.81
Volume
114,627
Avg. Vol
230,993
52-wk High
$358.45
52-wk Low
$154.68

Scaminace, Joseph 

Mr. Joseph M. Scaminace (Joe) is an Lead Independent Director of Cintas Corporation. e is designated as Lead Director of the Cintas Board of Directors and is Chairman of the Executive Committee and the Nominating and Corporate Governance Committee. Mr. Scaminace was Chairman, President and CEO of Vectra Corporation (formerly OM Group, Inc.), a diversified industrial growth company, from 2005 until his retirement in 2015. Prior to joining Vectra Corporation, Mr. Scaminace was the President and Chief Operating Officer of The Sherwin-Williams Company, a paint and coatings company, where he had worked in various capacities since 1983. He is a member of the Board of Trustees of The Cleveland Clinic. Mr. Scaminace is also a Director of Parker Hannifin Corporation. The Board believes that Mr. Scaminace's principal executive officer experience and service as a director of another publicly-traded company, which have provided him insight into high-level corporate governance and executive compensation matters, as well as his independent director status, make him an integral member of Cintas' Board.

Basic Compensation

Total Annual Compensation, USD 98,800
Restricted Stock Award, USD 70,089
Long-Term Incentive Plans, USD --
All Other, USD 70,017
Fiscal Year Total, USD 238,906

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Scott Farmer

8,621,240

Jon Hansen

2,699,970

Todd Schneider

4,019,080

Michael Thompson

2,645,810

Thomas Frooman

2,069,950

Joseph Scaminace

238,906
As Of  31 May 2019